These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 26968014

  • 1. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M, Flammer AJ, Enseleit F, Ruschitzka F.
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [Abstract] [Full Text] [Related]

  • 2. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L, Adhyaru B.
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [Abstract] [Full Text] [Related]

  • 3. Heart Failure Guidelines on Pharmacotherapy.
    Papadimitriou L, Hamo CE, Butler J.
    Handb Exp Pharmacol; 2017 Dec; 243():109-129. PubMed ID: 28451824
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    Lim WY, Woldman S.
    Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F, Lang CC, Struthers AD.
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacological therapy of heart failure with reduced ejection fraction].
    Wieser M, Rhyner D, Martinelli M, Suter T, Schnegg B, Bösch C, Wigger O, Dobner S, Hunziker L.
    Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
    [Abstract] [Full Text] [Related]

  • 11. Heart Failure.
    Wu A.
    Ann Intern Med; 2018 Jun 05; 168(11):ITC81-ITC96. PubMed ID: 29868816
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
    Albert NM, Tyson RJ, Hill CL, DeVore AD, Spertus JA, Duffy C, Butler J, Patterson JH, Hernandez AF, Williams FB, Thomas L, Fonarow GC.
    Am Heart J; 2021 May 05; 235():82-96. PubMed ID: 33497697
    [Abstract] [Full Text] [Related]

  • 14. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA, Mergenhagen KA, Del Carpio RO, Ho C.
    Ann Pharmacother; 2010 Oct 05; 44(10):1604-14. PubMed ID: 20841514
    [Abstract] [Full Text] [Related]

  • 15. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P.
    Ther Umsch; 2011 Feb 05; 68(2):71-9. PubMed ID: 21271537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of ACCF/AHA Stage C heart failure.
    Adigopula S, Vivo RP, DePasquale EC, Nsair A, Deng MC.
    Cardiol Clin; 2014 Feb 05; 32(1):73-93, viii. PubMed ID: 24286580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heart failure with preserved ejection fraction: a clinical dilemma.
    Komajda M, Lam CS.
    Eur Heart J; 2014 Apr 05; 35(16):1022-32. PubMed ID: 24618346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.